-+ 0.00%
-+ 0.00%
-+ 0.00%

Catalyst Pharmaceuticals publishes corporate presentation on rare disease medicines and USD 615-645 million 2026 revenue guidance

Reuters·03/10/2026 15:22:37

Please log in to view news